ISIN | CH0210193584 |
---|---|
Valor Number | 21019358 |
Bloomberg Global ID | UBS65QD SW |
Fund Name | UBS (CH) Suisse - 65 (CHF) Q-dist |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland | |
Distributor(s) |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Asset Class | Asset Allocation |
EFC Category | Multi-Asset Global Advanced Markets Aggressive |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | Well diversified portfolio with a focus on selected Swiss bonds, equities and real estate, complemented by a component of global bonds and equities|Equity weighting 65% |
Peculiarities |
Current Price * | 136.62 CHF | 08.08.2025 |
---|---|---|
Previous Price * | 136.60 CHF | 07.08.2025 |
52 Week High * | 137.78 CHF | 13.02.2025 |
52 Week Low * | 123.24 CHF | 09.04.2025 |
NAV * | 136.62 CHF | 08.08.2025 |
Issue Price * | 136.50 CHF | 08.08.2025 |
Redemption Price * | 136.50 CHF | 08.08.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 451,374,153 | |
Unit/Share Assets *** | 24,768,908 | |
Trading Information SIX |
YTD Performance | +4.77% |
31.12.2024 - 08.08.2025
31.12.2024 08.08.2025 |
---|---|---|
1 month | +0.34% |
08.07.2025 - 08.08.2025
08.07.2025 08.08.2025 |
3 months | +2.54% |
08.05.2025 - 08.08.2025
08.05.2025 08.08.2025 |
6 months | +0.34% |
10.02.2025 - 08.08.2025
10.02.2025 08.08.2025 |
1 year | +7.00% |
08.08.2024 - 08.08.2025
08.08.2024 08.08.2025 |
2 years | +14.49% |
08.08.2023 - 08.08.2025
08.08.2023 08.08.2025 |
3 years | +12.92% |
08.08.2022 - 08.08.2025
08.08.2022 08.08.2025 |
5 years | +20.87% |
10.08.2020 - 08.08.2025
10.08.2020 08.08.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
UBS (CH) InvF Eqs USAInd I-X-acc | 11.03% | |
---|---|---|
UBS CH IF3 RealEstSwitzFdsIdxNSL I-Xacc | 10.01% | |
UBS (CH) IF S&M Cap Equities Switz I-X | 9.00% | |
UBS (CH) IF-Bonds CHF Dom CI NSL U-X-acc | 7.09% | |
UBS (CH) IF Bo CHF F Corp I NSL U-X-acc | 4.85% | |
Nestle SA | 4.84% | |
UBS (CH) IF - Bnd CHF F Prime U-X-acc | 4.45% | |
Novartis AG Registered Shares | 4.29% | |
Roche Holding AG | 4.26% | |
UBS Core MSCI EMU UCITS ETF EUR dis | 4.02% | |
Last data update | 30.06.2025 |
TER | 1.05% |
---|---|
TER date | 31.08.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.95% |
Ongoing Charges *** | 1.06% |
SRRI ***
|
|
SRRI date *** | 31.07.2025 |